Biocon's Insulin Manufacturing Facility in Malaysia Completes USFDA inspection with three observations Medical Dialogues Bureau24 Feb 2020 12:11 PM ISTMalaysia:Drug major Biocon recently informed about the USFDA inspection at its Insulin Manufacturing Facility in Malaysia, and that the agency issued...
Medtronic, Novo Nordisk team up for integrating glucose monitoring, insulin dosing data to help diabetics Medical Dialogues Bureau18 Sept 2019 9:30 AM ISTThis new, non-exclusive collaboration reflects both Medtronic plc and Novo Nordisk commitment to make diabetes management easier by integrating key...
Diabetes Management: Sanofi, Abbott team up to integrate glucose sensing, insulin delivery technologies Farhat Nasim16 Sept 2019 9:30 AM ISTSanofi and Abbott will take an approach to connected care by developing tools that combine the revolutionary FreeStyle Libre technology with insulin...
USFDA Warning: Medtronic recalls insulin pumps over cybersecurity vulnerabilities Medical Dialogues Bureau29 Jun 2019 1:49 PM ISTThe recalled pumps are Medtronic's MiniMed 508 insulin pump and MiniMed Paradigm series insulin pumps. Medtronic is unable to adequately update the...
Sanofi to Partner with Google to use AI, Deep Analytics to find better treatments Medical Dialogues Bureau19 Jun 2019 11:58 AM ISTPARIS: French pharmaceutical firm Sanofi said Tuesday it is partnering with Google to use artificial intelligence and deep analytics tools to sift...
Cigna caps insulin prices at $25 for 30 days Medical Dialogues Bureau4 April 2019 9:00 AM ISTCigna, which bought pharmacy benefits manager Express Scripts last year, said it was partnering with insulin manufacturers to lower copayments to $25...
AstraZeneca gets EU nod to diabetes drug Forxiga Medical Dialogues Bureau27 March 2019 2:55 PM ISTFarxiga or Forxiga, as the drug is known outside the United States, is one of AstraZeneca's top ten drugs by sales. It generated $1.39 billion in 2018...
Setback: USFDA rejects Sanofi, Lexicon Sotagliflozin for type 1 diabetes Farhat Nasim24 March 2019 9:45 AM ISTThe decision comes about two months after an FDA advisory panel failed to reach a consensus over whether the once-daily oral drug, sotagliflozin,...
Novartis signs deal with Gan & Lee as US government seeks to slash insulin cost Medical Dialogues Bureau30 Dec 2018 9:20 AM ISTZURICH: Swiss drugmaker Novartis aims to become a big player in supplying insulin to swelling numbers of diabetics, signing a deal with China's Gan...
Sanofi, Novo Nordisk Eli Lilly accused of deceptive drug pricing of Insulin Medical Dialogues Bureau17 Oct 2018 3:16 PM ISTUS : Minnesota's attorney general on Tuesday filed a lawsuit accusing drug manufacturers Sanofi SA, Novo Nordisk and Eli Lilly and Co of deceptively...
Novo Nordisk wins EU panel's backing for key diabetes drug Ruby Khatun Khatun18 Dec 2017 10:30 AM ISTCOPENHAGEN: Danish drugmaker Novo Nordisk came closer to winning European approval for diabetes drug Ozempic, it's biggest growth prospect when a...
FDA approves Novo Nordisk diabetes drug Ozempic Ruby Khatun Khatun6 Dec 2017 10:30 AM ISTThe U.S. Food and Drug Administration on Tuesday approved Novo Nordisk A/S's diabetes drug Ozempic, setting the stage for a heated battle with Eli...
